Follow the people · Insider
Jonathan Gillis
Jonathan Gillis files insider transactions with the SEC as a cao and interim cfo of MapLight Therapeutics (MPLT). We hold 6 disclosed purchases and sales filed since 23 June 2017, 3 of them in the last 90 days.
- Files forMPLT
- Disclosed buys and sells6 in all, 3 in the last 90 days
- Last disclosure19 August 2026
Positions held
3 posts we hold — a term names its own dates; a run of filings only says when they filed- Filed 27 October 2025 — 17 August 2026CAO and Interim CFO · MapLight Therapeutics (MPLT)25 Form 4 lines · source: SEC Form 4
- Filed 10 May 2018 — 10 May 2018Senior Vice President, Finance · Millendo Therapeutics (MLND)1 Form 4 line · source: SEC Form 4
- Filed 21 June 2017 — 8 February 2018Senior Vice President, Finance · OvaScience (OVAS)2 Form 4 lines · source: SEC Form 4
Everything they disclosed
28 entries, newest first — one per disclosure report, one per Form 4 line- was granted 6,020 shares of MapLight TherapeuticsSEC Form 419 August 2026Voting Common Stock · traded 17 August 2026 · filed 19 August 2026
- was granted 2,222 shares of MapLight TherapeuticsSEC Form 419 August 2026Voting Common Stock · traded 17 August 2026 · filed 19 August 2026
- was granted 24,455 shares of MapLight Therapeutics (a derivative holding)SEC Form 419 August 2026Employee Stock Option (right to buy) · traded 17 August 2026 · filed 19 August 2026
- was granted 2,813 shares of MapLight Therapeutics (a derivative holding)SEC Form 419 August 2026Employee Stock Option (Right to Buy) · traded 17 August 2026 · filed 19 August 2026
- ▼ sold on the open market 5,356 shares of MapLight TherapeuticsSEC Form 420 July 2026Voting Common Stock · traded 15 July 2026 · filed 20 July 2026
- ▼ sold on the open market 4,699 shares of MapLight TherapeuticsSEC Form 420 July 2026Voting Common Stock · traded 15 July 2026 · filed 20 July 2026
- ▼ sold on the open market 6,979 shares of MapLight TherapeuticsSEC Form 420 July 2026Voting Common Stock · traded 16 July 2026 · filed 20 July 2026
- ▼ sold on the open market 1,476 shares of MapLight TherapeuticsSEC Form 420 July 2026Voting Common Stock · traded 16 July 2026 · filed 20 July 2026
- ▼ sold on the open market 600 shares of MapLight TherapeuticsSEC Form 420 July 2026Voting Common Stock · traded 17 July 2026 · filed 20 July 2026
- ▼ sold on the open market 16,969 shares of MapLight TherapeuticsSEC Form 420 July 2026Voting Common Stock · traded 17 July 2026 · filed 20 July 2026
- ▼ sold on the open market 900 shares of MapLight TherapeuticsSEC Form 420 July 2026Voting Common Stock · traded 17 July 2026 · filed 20 July 2026
- ▼ sold on the open market 7,914 shares of MapLight TherapeuticsSEC Form 429 April 2026Voting Common Stock · traded 27 April 2026 · filed 29 April 2026
- ▼ sold on the open market 29,623 shares of MapLight TherapeuticsSEC Form 429 April 2026Voting Common Stock · traded 27 April 2026 · filed 29 April 2026
- ▼ sold on the open market 14,363 shares of MapLight TherapeuticsSEC Form 429 April 2026Voting Common Stock · traded 27 April 2026 · filed 29 April 2026
- ▼ sold on the open market 17,235 shares of MapLight TherapeuticsSEC Form 429 April 2026Voting Common Stock · traded 28 April 2026 · filed 29 April 2026
- ▼ sold on the open market 700 shares of MapLight TherapeuticsSEC Form 429 April 2026Voting Common Stock · traded 28 April 2026 · filed 29 April 2026
- ▼ sold on the open market 3,590 shares of MapLight TherapeuticsSEC Form 417 April 2026Voting Common Stock · traded 15 April 2026 · filed 17 April 2026
- was granted 6,020 shares of MapLight TherapeuticsSEC Form 49 February 2026Voting Common Stock · traded 5 February 2026 · filed 9 February 2026
- was granted 24,455 shares of MapLight Therapeutics (a derivative holding)SEC Form 49 February 2026Employee Stock Option (right to buy) · traded 5 February 2026 · filed 9 February 2026
- was granted 24,455 shares of MapLight Therapeutics (a derivative holding)SEC Form 49 February 2026Employee Stock Option (right to buy) · traded 5 February 2026 · filed 9 February 2026
- was granted 6,020 shares of MapLight TherapeuticsSEC Form 49 February 2026Voting Common Stock · traded 5 February 2026 · filed 9 February 2026
- had shares withheld for tax on 22,050 shares of MapLight TherapeuticsSEC Form 429 January 2026Voting Common Stock · traded 27 January 2026 · filed 29 January 2026
- had shares withheld for tax on 22,050 shares of MapLight TherapeuticsSEC Form 429 January 2026Voting Common Stock · traded 27 January 2026 · filed 29 January 2026
- was granted 124,022 shares of MapLight Therapeutics (a derivative holding)SEC Form 428 October 2025Employee Stock Option (right to buy) · traded 27 October 2025 · filed 28 October 2025
- was granted 30,565 shares of MapLight TherapeuticsSEC Form 428 October 2025Voting Common Stock · traded 27 October 2025 · filed 28 October 2025
- was granted 5,000 shares of Millendo Therapeutics (a derivative holding)SEC Form 411 December 2018Employee Stock Option (right to buy) · traded 10 May 2018 · filed 11 December 2018
- was granted 128,645 shares of OvaScience (a derivative holding)SEC Form 49 February 2018Stock Option (right to buy) · traded 8 February 2018 · filed 9 February 2018
- was granted 30,000 shares of OvaScience (a derivative holding)SEC Form 423 June 2017Stock Option (right to buy) · traded 21 June 2017 · filed 23 June 2017
Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.